Minerva Surgical, Inc. (UTRS) News & Overview - Discounting Cash Flows
UTRS
Minerva Surgical, Inc.
UTRS (OTC)

UTRS's Business Model

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Sector & Industry Healthcare / Medical - Healthcare Information Services
Website https://minervasurgical.com
CEO (Chief Executive Officer) Darin Hammers
Number of Employees
IPO date October 22, 2021

UTRS Latest News

Contact
CountryUS
Address4255 Burton Drive
CitySanta Clara
StateCA
Phone855 646 7874
Zip Code95054
Other Identifiers
CIK0001452965
ISINUS60343F2056
CUSIP60343F106
Open0.0001
Previous Close0.0001
Volume500
Average Volume225
Day’s Range0.0001 – 0.0001
52 Week Range0.00001-0.001
MA (50)0.000128
MA (200)0.0002463
Market Cap888
Shares Out.8.88 Mil.
Earnings DateMar 25, 2026
Beta
Last Dividend
EPS
PE

Industry Competitors for UTRS

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program